Findings from a population based cross-sectional study suggests that while up to 20% of patients have antibodies to tick-borne exposures, only a minority reported musculoskeletal symptoms. 

EULAR has published the 2023 updated recommendations for the optimal non-pharmacological management of hip and knee osteoarthritis (OA). Non-pharmacological treatments for OA are as important and impactful at improving pain, function and quality of life in OA. These EULAR recommendations were originally published in 2013.

A study published in Nature suggests that therapies affecting sodium channels could be employed to treat osteoarthritis. Osteoarthritis (OA) affects 528 million people worldwide and yet there are no uniformly effective treatments - other than joint replacement.  The ideal therapeutic intervention would both prevent/manage pain while preventing cartilage degeneration and joint damage.